Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Dose-Finding, Placebo-Controlled Study

NCT00182780 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00182780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00182780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Dose-Finding, Placebo-Controlled Study
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2005
Completion date
April 30, 2010
Enrollment
290 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, unspecified adult solid tumor, protocol specific